Answers are grounded in this paper and cite their sources.
The early clinical features of autoimmune encephalitis (AE) substantially overlap with those of viral encephalitis (VE), a diagnostic ambiguity that frequently prompts concurrent empirical antiviral and immunosuppressive therapies. This strategy entails antiviral-induced hepatotoxicity or nephrotoxicity and secondary infections from immunosuppression. Thus, precise early differentiation between AE and VE is imperative. A recently developed risk score termed UT–Hopkins Score distinguishes these entities in adults and has been validated in European and American populations, but its generalizability to Asian cohorts remains undetermined. This retrospective single-center study enrolled patients diagnosed with VE or AE between January 2017 and November 2024. Eligible patients had compatible clinical syndromes and CSF-supported etiological evidence, defined as CSF virological evidence for VE obtained by metagenomic next-generation sequencing or pathogen-specific antibody, and a CSF neural antibody for AE, and the UT–Hopkins score, a four-item tool ranging from 0 to 4 that incorporates age-adjusted comorbidity, symptom duration, psychiatric/memory features, and CSF white blood cell count and protein, was reconstructed for each case. Discriminatory performance was quantified by area under the receiver operating characteristic curve. Sensitivity, specificity, and predictive values for AE were subsequently calculated, and diagnostic performance was evaluated at the published thresholds of ≥ 2 and ≥ 3. A total of 113 patients were included, comprising 63 with VE and 50 with AE. The risk score yielded an area under the curve of 0.919 (95% CI 0.869–0.969). Applying a clinically convenient cutoff of 2 points or higher for AE identification produced a sensitivity of 92.0%, a specificity of 82.5%, a positive predictive value of 80.7%, and a negative predictive value of 92.9%. At ≥ 3 points, sensitivity was 58.0%, specificity 95.2%, positive predictive value 90.6%, negative predictive value 74.1% for AE identification. The UT–Hopkins score demonstrates robust validity and excellent discriminative ability in a Chinese cohort for the first time. A threshold of ≥ 2 favoured sensitivity, whereas ≥ 3 provided greater specificity. A threshold of ≥ 2 points is recommended for clinical use in China, positioning this score as an efficient tool for suspected encephalitis patients.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: